Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study

BACKGROUND: Many thrombotic complications are linked to coronavirus disease 2019 (COVID-19). Antithrombotic treatments are important for prophylaxis against these thrombotic events. OBJECTIVES: This study was designed to compare enoxaparin and rivaroxaban as prophylactic anticoagulants in moderate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Asmaa S., Ahmad, Hosam M., Abdul-Raheem, Alyaa S.A., Kamel, Fatma M.M., Khames, Ali, Mady, Ahmed F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288247/
https://www.ncbi.nlm.nih.gov/pubmed/35864037
http://dx.doi.org/10.1016/j.sapharm.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288247/
https://www.ncbi.nlm.nih.gov/pubmed/35864037
http://dx.doi.org/10.1016/j.sapharm.2022.07.004

Ejemplares similares